---
figid: PMC3023029__mbt0004-0032-f2
figtitle: Intracellular transport pathway of Shiga toxin
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC3023029
filename: mbt0004-0032-f2.jpg
figlink: /pmc/articles/PMC3023029/figure/f2/
number: F2
caption: The intracellular transport pathway of Shiga toxin. Upon binding to the receptor
  Gb3, Shiga toxin is taken in by both clathrin‐dependent and clathrin‐independent
  pathways, and the toxin–receptor complex is transported in a retrograde manner from
  early endosomes (EE) to the trans‐Golgi network (TGN), the Golgi apparatus and further
  to the endoplasmic reticulum (ER). The enzymatically active A1 fragment is then
  translocated into the cytosol where its N‐glycosidase activity irreversibly modifies
  the ribosomal 28S RNA, which leads to inhibition of protein synthesis. Components
  reported to be involved in Stx transport are indicated at each step along the pathway
  (for references see ; ; ; ; ).
papertitle: Shiga toxin and its use in targeted cancer therapy and imaging.
reftext: Nikolai Engedal, et al. Microb Biotechnol. 2011 Jan;4(1):32-46.
year: '2011'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8966438
figid_alias: PMC3023029__F2
figtype: Figure
redirect_from: /figures/PMC3023029__F2
ndex: 97deeef8-dec3-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3023029__mbt0004-0032-f2.html
  '@type': Dataset
  description: The intracellular transport pathway of Shiga toxin. Upon binding to
    the receptor Gb3, Shiga toxin is taken in by both clathrin‐dependent and clathrin‐independent
    pathways, and the toxin–receptor complex is transported in a retrograde manner
    from early endosomes (EE) to the trans‐Golgi network (TGN), the Golgi apparatus
    and further to the endoplasmic reticulum (ER). The enzymatically active A1 fragment
    is then translocated into the cytosol where its N‐glycosidase activity irreversibly
    modifies the ribosomal 28S RNA, which leads to inhibition of protein synthesis.
    Components reported to be involved in Stx transport are indicated at each step
    along the pathway (for references see ; ; ; ; ).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CLTA
  - CLTB
  - CLTC
  - SYK
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - DYNC1H1
  - DYNC1I1
  - DYNC1I2
  - DYNC1LI1
  - DYNC1LI2
  - DYNLL1
  - DYNLL2
  - DYNLRB1
  - DYNLRB2
  - DYNLT1
  - DYNLT3
  - DYNC2H1
  - DYNC2LI1
  - DYNLT2B
  - DYNC2I1
  - DYNC2I2
  - DNAI7
  - DNAH1
  - DNAH10
  - DNAH12
  - DNAH14
  - DNAH2
  - DNAH3
  - DNAH6
  - DNAH7
  - DNAI3
  - DNAI4
  - DNAH11
  - DNAH17
  - DNAH5
  - DNAH8
  - DNAH9
  - DNAI1
  - DNAI2
  - DNAL1
  - DNAL4
  - DYNLT2
  - CDC42
  - SNX2
  - SNX1
  - ARHGAP21
  - SNX8
  - RBSN
  - EHD3
  - PIK3C3
  - MAPK14
  - DNAJC13
  - ARL1
  - AKR1B10
  - HSPA8
  - GCC2
  - VAMP3
  - BET1L
  - STX16
  - VTI1A
  - RAB6A
  - ERC1
  - GOLGA1
  - CNGB1
  - LRRC32
  - VPS51
  - VPS52
  - VPS53
  - VPS54
  - SNTG2
  - YKT6
  - GOSR1
  - TG
  - RAB33B
  - RAB43
  - USP6NL
  - TMF1
  - YIPF5
  - MYH14
  - MYO6
  - MYO10
  - MYO16
  - MYO19
  - MYH1
  - MYH10
  - MYH11
  - MYH13
  - MYH15
  - MYH16
  - MYH2
  - MYH3
  - MYH4
  - MYH6
  - MYH7
  - MYH7B
  - MYH8
  - MYH9
  - MYO1A
  - MYO1B
  - MYO1C
  - MYO1D
  - MYO1E
  - MYO1F
  - MYO1G
  - MYO1H
  - MYO3A
  - MYO3B
  - MYO5A
  - MYO5B
  - MYO5C
  - MYO7A
  - MYO7B
  - MYO9A
  - MYO9B
  - MYO15A
  - MYO15B
  - MYO18A
  - MYO18B
  - MYL1
  - MYL3
  - MYL4
  - MYL6
  - MYL6B
  - MYL10
  - MYL12A
  - MYL12B
  - MYL2
  - MYL5
  - MYL7
  - MYL9
  - MYL11
---
